The arginine-nitric oxide pathway: a target for new drugs.
Kerwin
J F
JF
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064.
Heller
M
M
D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics; D000595:Amino Acid Sequence; D000818:Animals; D001120:Arginine / Q000187:drug effects* / Q000378:metabolism; D002320:Cardiovascular Physiological Phenomena; D006801:Humans; D008969:Molecular Sequence Data; D009424:Nervous System Physiological Phenomena; D009569:Nitric Oxide / Q000096:biosynthesis / Q000737:chemistry / Q000502:physiology*; D019001:Nitric Oxide Synthase; D012016:Reference Values; D013379:Substrate Specificity
D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases